S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
Is CRISPR Therapeutics the NVIDIA of gene editing?
Critical asset just had biggest fall on record (Ad)
These 2 carnivore dining stocks gaining on the Ozempic craze
This healthcare stock making a buzz with 160% growth
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
First it was Tyson stock, now this food company is set to rally
How major US stock indexes fared Monday, 2/26/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
This infrastructure construction stock: Is it ready to pop?
Is Roku worth a second look after the earnings panic selloff?

NeuroOne Medical Technologies (NMTC) Earnings Date, Estimates & Call Transcripts

$1.16
+0.09 (+8.41%)
(As of 02/26/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Feb. 13)
-$0.14 Missed By -$0.14
Skip Charts & View Estimated and Actual Earnings Data

NMTC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NMTC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NMTC Earnings Date and Information

NeuroOne Medical Technologies last released its quarterly earnings data on February 13th, 2024. The reported ($0.14) EPS for the quarter. The firm earned $0.98 million during the quarter. NeuroOne Medical Technologies has generated ($0.68) earnings per share over the last year (($0.68) diluted earnings per share). NeuroOne Medical Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

NeuroOne Medical Technologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
2/13/2024Q1 2024-($0.14)($0.14)($0.14)-$0.98 million    
12/14/2023Q3 2023($0.18)($0.17)+$0.01($0.13)-$0.74 million    
8/14/2023Q3 2023-($0.20)($0.20)($0.20)-$0.63 million    
5/11/2023Q2 2023-($0.21)($0.21)($0.21)-$0.47 million
2/14/2023Q1 2023-($0.11)($0.11)($0.11)-$0.11 million    
12/22/2022Q4 2022-($0.09)($0.09)($0.09)-$0.07 million
8/11/2022Q3 2022-($0.17)($0.17)($0.17)-$0.03 million
5/12/2022Q2 2022-($0.19)($0.19)($0.19)-$0.04 million
2/14/2022Q1 2022-($0.18)($0.18)($0.18)-$0.04 million    
12/15/2021Q3 2021($0.24)($0.22)+$0.02($0.22)-$0.05 million    
8/13/2021Q3 2021-($0.25)($0.25)($0.25)-$0.04 million












NeuroOne Medical Technologies Earnings - Frequently Asked Questions

When is NeuroOne Medical Technologies's earnings date?

NeuroOne Medical Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on NMTC's earnings history.

How can I listen to NeuroOne Medical Technologies's earnings conference call?

The conference call for NeuroOne Medical Technologies's latest earnings report can be listened to online. Listen to Conference Call

How can I read NeuroOne Medical Technologies's conference call transcript?

The conference call transcript for NeuroOne Medical Technologies's latest earnings report can be read online. Read Transcript

How much revenue does NeuroOne Medical Technologies generate each year?

NeuroOne Medical Technologies (NASDAQ:NMTC) has a recorded annual revenue of $2.82 million.

How much profit does NeuroOne Medical Technologies generate each year?

NeuroOne Medical Technologies (NASDAQ:NMTC) has a recorded net income of -$11.86 million. NMTC has generated -$0.68 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:NMTC) was last updated on 2/27/2024 by MarketBeat.com Staff